Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study 2025-08-28 07:45
Harbour BioMed Reports 2025 Interim Results 2025-08-27 22:40
Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0 2025-08-27 21:30
Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states 2025-08-27 20:00
Innovent Announces 2025 Interim Results and Business Updates 2025-08-27 18:08
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum 2025-08-27 14:02
Crescom to Showcase Musculoskeletal AI Innovations at 26th Asian Musculoskeletal Society Annual Meeting 2025-08-27 09:00
Cerecin Joins NIHR HealthTech Research Centre in Brain Health as an Industry Partner 2025-08-27 00:04
iNtRON Bio, files Two Patent Applications for IMPA™ Platform-Based Gene Editing Technology 2025-08-26 21:00
Fosun Pharma Announces 2025 Interim Results 2025-08-26 20:42
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment 2025-08-26 14:29
Neopharma Technologies and Orient Gene Partner to Digitize Healgen® Drug Test Portfolio Globally with NEOVAULT® 2025-08-26 02:10
Henlius Keeps Steady Growth in H1 2025: Overseas Product Profits Soar 200%+, Innovation Fuels Global Reach 2025-08-25 21:18
Everest Medicines Announces Participation in September Investor Conferences 2025-08-25 20:57
Peijia Medical Announces 2025 Interim Results 2025-08-25 20:00
Acceleration in Clinical Development! Leads Biolabs' LBL-034 Dosed First Patient in Phase Ⅱ Trial 2025-08-25 18:27
Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy 2025-08-25 15:43
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints 2025-08-25 13:46
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts 2025-08-25 12:01
Harbour BioMed Appoints Yajie Li as Chief Medical Officer 2025-08-25 09:00